Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells

被引:0
作者
Parker, G [1 ]
Fernandes, H [1 ]
Chong, SY [1 ]
Czarneski, J [1 ]
Ra, H [1 ]
Lin, YC [1 ]
Raveche, E [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA
关键词
tumor immunity; cytokines; IL-10; gene therapy; in vivo animal models;
D O I
10.1080/mccm.6.3.113.119
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interleukin-10 (IL-10) is a pleiotropic cytokine that has a variety of downregulatory effects on immunologic and inflammatory processes. Ectopic tumor expression of IL-10 inhibited tumor growth, and local administration of antisense IL-10 significantly reversed the effects of IL-10 transfection in P815 mastocytoma. Tissue inhibitors of metalloproteinase (TIMPs) have been associated with decreased tumorigenesis and reduced metastasis, and TIMPs were increased in the region surrounding P815/IL-10 tumors and reduced in antisense IL-10-treated mice. in addition, the antisense IL-10 group had the largest tumor volume and poorest survival when compared with the P815/IL-10 control or sense groups. In summary, our data suggest that, in a mouse model, antisense IL-10 has substantive effects in reducing IL-10 translation and inhibiting IL-10-mediated TIMP upregulation, and, by doing so, allows IL-10-transfected mastocytoma to grow unchecked. Thus, ectopic tumor expression of IL-10 inhibits tumor growth, and antisense IL-10 administration in vivo reverses this protective effect.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 42 条
  • [1] In vitro and in vivo anti-influenza A virus activity of antisense oligonucleotides
    Abe, T
    Mizuta, T
    Suzuki, S
    Hatta, T
    Takai, K
    Yokota, T
    Takaku, H
    [J]. NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (6-7): : 1685 - 1688
  • [2] IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response
    Adris, SK
    Klein, S
    Jasnis, MA
    Chuluyan, E
    Ledda, MF
    Bravo, AI
    Carbone, C
    Chernajovsky, Y
    Podhajcer, OL
    [J]. GENE THERAPY, 1999, 6 (10) : 1705 - 1712
  • [3] Antisense inhibition of expression of the light subunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence
    Ankri, S
    Padilla-Vaca, F
    Stolarsky, T
    Koole, L
    Katz, U
    Mirelman, D
    [J]. MOLECULAR MICROBIOLOGY, 1999, 33 (02) : 327 - 337
  • [4] Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5′ and 3′ regions
    Bigeriego, P
    Rosas, MF
    Zamora, E
    Martínez-Salas, E
    Sobrino, F
    [J]. ANTIVIRAL RESEARCH, 1999, 44 (02) : 133 - 141
  • [5] CHEN WF, 1991, J IMMUNOL, V147, P528
  • [6] Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems
    Clark, RE
    [J]. LEUKEMIA, 2000, 14 (03) : 347 - 355
  • [7] DE WMR, 1991, J EXP MED, V174, P1209
  • [8] PROTEASE INHIBITORS - ROLE AND POTENTIAL THERAPEUTIC USE IN HUMAN CANCER
    DECLERCK, YA
    IMREN, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) : 2170 - 2180
  • [9] Fallarino F, 1996, J IMMUNOL, V156, P1095
  • [10] FERNANDES H, 1995, ONCOL REP, V2, P985